Replacement of the interchain disulfide bridge-forming amino acids A7 and B7 by glutamate impairs the structure and activity of insulin

Key Laboratory of Proteomics, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, The Chinese Academy of Sciences, Shanghai 200031, PR China.
Biological Chemistry (Impact Factor: 2.69). 01/2005; 385(12):1171-5. DOI: 10.1515/BC.2004.151
Source: PubMed

ABSTRACT Insulin contains three disulfide bonds, one intrachain bond, A6-A11, and two interchain bonds, A7-B7 and A20-B19. Site-directed mutagenesis results (the two cysteine residues of disulfide A7-B7 were replaced by serine) showed that disulfide A7-B7 is crucial to both the structure and activity of insulin. However, chemical modification results showed that the insulin analogs still retained relatively high biological activity when A7Cys and B7Cys were modified by chemical groups with a negative charge. Did the negative charge of the modification groups restore the loss of activity and/or the disturbance of structure of these insulin analogs caused by deletion of disulfide A7-B7? To answer this question, an insulin analog with both A7Cys and B7Cys replaced by Glu, which has a long side-chain and a negative charge, was prepared by protein engineering, and its structure and activity were analyzed. Both the structure and activity of the present analog are very similar to that of the mutant with disulfide A7-B7 replaced by Ser, but significantly different from that of wild-type insulin. The present results suggest that removal of disulfide A7-B7 will result in serious loss of biological activity and the native conformation of insulin, even if the disulfide is replaced by residues with a negative charge.


Available from: Zhan-Yun Guo, May 11, 2014
  • Source
  • [Show abstract] [Hide abstract]
    ABSTRACT: Insulin is not only a very important protein hormone in clinic but also a perfect model molecule in protein science. Almost each important achievement in the field of protein science was established from insulin study, such as protein crystal, protein sequence, protein synthesis, protein expression, and protein engineering since its discovery by Banting and Best in 1921. However, concerning in vitro folding of insulin it was not well characterized until the early 2000, probably the major difficult being that insulin consists of two polypeptide chains linked by disulfides. Because insulin is synthesized in vivo as a single chain peptide and folds well, recently the study on the in vitro folding of insulin has been investigated from single chain insulin to double chain insulin. This chapter briefly summarizes the current studies on the in vitro folding of single/double chain insulins and related proteins including their folding process, intermediates, and putative folding pathways. Besides, the common folding behavior of single/double chain insulins and related proteins and the in vivo folding process of nascent proinsulin, as suggestion or speculation, are discussed. KeywordsInsulin-Proinsulin-Porcine insulin precursor-Amphioxus insulin-like peptide-Insulin-like growth factor-1-Disulfide-containing protein-Folding-Folding process-Folding intermediate-Putative folding pathway
    08/2011: pages 63-89;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Therapeutic proteins require correct disulfide bond formation for biological activity and stability. This makes their manufacturing and storage inherently challenging since disulfide bonds can be aberrantly formed and/or undergo significant structural changes. In this paper the mechanisms of disulfide bond formation and scrambling are reviewed, with a focus on their impact on the biological activity and storage stability of recombinant proteins. After assessing the research progress in detecting disulfide bond scrambling, strategies for preventing this phenomenon are proposed.
    Biotechnology advances 07/2011; 29(6):923-9. DOI:10.1016/j.biotechadv.2011.07.013 · 8.91 Impact Factor